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INTRODUCTION 
The term " Inflammatory Bowel Disease" (IBO) refers to a g roup 
of chronic di sorders of the intestines, whose features are largely 
nonspecif i c. Of all chronic bowel inflammations, those that do not show 
characteristics of a particular etiological group such as bacterial, 
v ira l , parasitic and allergic disease, fall into t hi s categor y . IBO has 
been known to affect many spec i es. Being of unknown etiology, the only 
consistent f eature of thi s di sease is its chronic infl ammato ry nature, 
involving mucosal infiltration of inflammatory cells, whose type may vary 
between cases. The most common clinica l feature is chronic recurrent 
diarrhea with muco id and sometimes bloodstained stools . Oth er s igns like 
vomition, weight loss and alteration of appetite are frequently present. 
IBO i s common in canin es , and presents a chal lenge to the vete r inar i a n 
due to its nonspecific nature which makes both diagnosis and treatment 
quite difficult. 
The standard diagnostic proce dure begins with e limination of oth e r 
possible causes which may bring about similar symptoms. The methods 
currently available for a relatively specific diagnosis of IBD are 
endoscopy of the colon and hi stopathological examination of biopsy 
specimens from affected areas. The treatments used in IBO include dietary 
management , anti-inflammatory therapy a nd symptomatic therapy wh i ch may 
or may not be successful in a ll cases. There are three types of dietary 
therapy used in IBO. One i s withholding food whereby the bowe l is placed 
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in a state of physiologic r est for 1-2 days . Another category is the 
fe e ding of a non-allergenic diet such as cottage cheese and rice, since 
some cases of IBO are caused by a sen s itivity to a dietary protein. A 
non-allergenic diet preceded by bowel pre paration by two days of fasting 
i s recommended . Another helpful dietary a pproach is supp l ementation with 
fiber, which increases fe cal bulk, stretches co lonic smooth muscle and 
increases contractility. Anti-in f l ammato r y the rapy with drugs like 
sulfasalazine (antimicrobial and a nti-inflammatory), prednisolone 
(co r t i c osteroid ) and azathioprine (immunosuppressant) i s the basis of 
treatment in most cases of IBO, and h elps to ame l iorate the chronic 
inflammation. Symptoma t ic therapy involves decrease of feca l water and 
alte ration of colonic motili ty by opiates such as loperamide (Sherding 
and Burrows, 1992) . 
Recent s tudies in humans (O 'Mahoney et a l. , 1990, 1991; Choudari et 
al . , 1993 ; Kubes, 1992 ; Roediger et al. , 1 986; Miller et a l., 1992) have 
brought to attention two f actors which may be useful in the diagnosis and 
treatment of IBO. These are: a) gut lavage fluid protein concentrations 
as a diagnostic marke r of disease activity; and b) the role of nitric 
oxide synthase in the inflamma tory process, which may be applicable in 
both diagnosis and therapy. 
Several studies with whole g u t l avage fluid (O'Mahoney et al., 
1990, 1991; Choudar i et a l ., 1993) have repeatedly shown elevated levels 
of Immunoglobulin G ( IgG) and albumin in patients with act ive IBO as 
opposed to those of normal subjects or inactive IBO patients, indicating 
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this might be a suitable diagnostic parameter for identifying the active 
disease. Such studies have not been conducted in canines, and one 
objective of this investigation was to test whether gut lavage fluid IgG 
concentration is a reliable marker for active IBD in dogs. 
Nitric oxide (NO), synthesized from L-arginine by the enzyme NO 
synthase, has been known to play a role in circulatory and neural 
physiology. Several recent studies have revealed that there may be an 
increase in NO production in IBD, which may be a contributor y factor to 
the inflammatory process. According to Roediger et al. (1986), rectal 
dialysates of human patients with active ulcerative colitis contained 
elevated luminal nitrite level s, while nitrite was immeasurable in 
patients with quiescent colitis. Nitrite is the stable end product of 
nitric oxide. In a guinea pig mod e l of ileitis, luminal nitrite level s 
were increased threefold and the inflammatory process could be prevented 
by oral administration of L-arginine antagonists which inhibit NO 
synthase (Miller et al., 1992). These studies suggest that enhanced NO 
synthesis may contribute to the mucosal injury in IBD, and this effect 
may be prevented by administration of L-arginine antagonists. Since the 
role of nitric oxide in canine IBD has not been investigated, a second 
objective of the present research was to evaluate the usefulness of 
colonic nitrite levels as a rapid diagnostic indication of act i ve disease 
in the dog. 
To determine the significance of these two paramete rs in IBD, it is 
necessary to assess the presenc e and degree of disease activ i ty in 
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an imals suspected of having IBD. In addition to hi stological examination 
of colonic biopsy specimens for inflammatory lesions, we measured the 
activity of t h e enzyme myeloperoxidase (MPO) in colonic lavage as an 
indicator of disease activity. MPO is an e n zyme found in granulocytes, 
wh i ch are usuall y found in large numbers at sites of inflammation . The 
activity of t h is enzyme has been used as a measure of the degree of 
inflammation in severa l previous studies (Brad l ey et al., 1 982; Miller et 
al., 1 991). 
5 
LITERATURE REVIEW 
The Norma l Large Intestine 
Histology and physiology 
The l arge intestine is the part of the gut that begins at the 
i leocecal junct ion and ends at the externa l orifice or a nus. The parts of 
t he canine large intestine are the cecum, the colon, and the r ectum. In 
humans, the large intestine is more complex, hav ing an init ial bl ind 
pouch and ascending, transverse, descending and sigmoid regions in the 
colon . Its principal functions are reabsorption of water and 
electrolytes, and the elimination of undigested material. The 
histophysiolog i cal f eatur es o[ the large intestine are simi l a r in canines 
and humans. 
The histology of the large inLesLine is bas i cally s imilar in 
general structure to al l other parts of the gastro -intestinal tract. This 
general structure consists of four concentric layers, namely the mucosa, 
the submucosa, the muscul aris and the serosa, respectively fr om the lume n 
outward. The mucosa consists of: a) a superficial epithelium in direct 
contact with the lumen b) t h e lamina propria, whic h is the under l y ing 
stroma containing l oose connective tissue, b l ood vessels and immune 
cells, and c) the mus c ular i s mucosa, which is a relatively thin laye r of 
smooth muscle. The submucosa consists of collagenous connect ive tissue , 
containing few cells except for accumu lations of lymphoid tissue. The 
submucosa also contains large blood and l y mph vessels and nerve plexuses. 
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The muscularis consists of two layers of smooth muscle, the inner layer 
arranged in a circular fashi on and the outer layer in a longitudinal 
fashion. The funct i on of these muscle layers is to bring about movement 
of chyme along t h e lumen, the contraction of t h e ci r cul ar mu sc l es causing 
the cons triction of the lumen and the contraction of the longitudinal 
muscles causing s hor tening of the tube. The serosa or advent i tia, 
consisting of several layers of loose connect ive tissue, co llagenous and 
elastic alternately, is the outermost layer of the gut (Neutra, 1988; 
Banks, 1993). 
The structure of the large intestine is specifically arranged 
according to its functions. Since absorption of nutrients is very limited 
h ere, the mucosal surface i s flat and without villi, in contrast to t h e 
small intestine. Straight tubular glands (crypts) from the surface extend 
to the muscularis mucosae. The epithelium of these glands contain large 
numbers of goblet cells, which secrete mucus to lubricate t h e s urface and 
to facilitate the passage of solid and dehydrated lumina l contents. This 
mucus a lso protects the mucosa from c h emical and mechanica l inj ury. Very 
large numbers of bacteria inhabit the lumen of the normal large 
intestine. Many of these bacLeria help the hosL by digesting res idual 
organic matter in the luminal contents and synthesizing trace amounts of 
nu trients, which may be absorbed through the s urface epithelium . I n 
protection against possible invasion by luminal bacteria, there is an 
abundance of lymphoid cells and nodules throughout the large i ntestine. 
The epithelium lining the surface and crypts of the large intestine is of 
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simple co lumnar type , and is constantly renewe d . The cryp t epithelium 
contains undiffe rentiated cells, immature absorptive cel l s , goblet cells 
and enteroendocrine cel l s, whil e mature absorptive cells and goblet cells 
predominate in the surface ep i thel ium. The apical surfaces of the 
absorptive cells contain microvilli, which help in the absorption of 
water and small amounts of nutrients t hat occur in the large intestine. 
The bottoms of the cry pts contain an a bundance of undifferentiated cells, 
which gradually diffe rentiate and beco1ne mature functional ce l ls as they 
reach the surface . The colonic secreLions have an alkaline pH, which 
helps prevent mucosa l irritation by neutralizing acids produced by 
luminal bacteria (Neutra, 1988 ; Banks, 1993). 
The colon has different types of muscular co ntract ions to ensur e 
proper function . There are slow wave contractions which cause peristaltic 
and antiperistaltic movements, segmental con tractions which br ing about 
mixing of the ingesta, and mass contracti l e movements to propel feces 
towards the anal orifice (Neutra, 1988; Banks, 1993) . 
Apart from water, the main subs tance absorbed in the large 
intestine is salt. For this purpose, the baso-lateral me mbrane of the 
surface absorptive cells is rich in Na-K-dependent ATPase. Sodium is 
ac tively absorbed a nd ch loride is passively absorbed along with water, 
while potassium and bicarbonate are secre ted into the lumen. Although 
dietary fat absorption is normally completed in the small intestine, 
sometimes lipids can enter the colon when there is incomplete absorption. 
In the surface epithelium of the ascending colon, absorption of fatty 
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ac ids, resynthes i s of triglycerides, and formation and release of 
c hy lomicrons does occur, although less efficiently than in the smal l 
intestine. The passage of luminal contents is largely facil i tated by the 
continuous secretion of muc u s by the goblet c e lls, one of which occurs 
for about every four of the co lumnar ce lls. (Neutra, 1988; Banks, 1993). 
Immuno logy 
DPfense mechanisms arP vPry imporcant co the gastrointestinal tract 
because of its cont inuo u s exposure to potentially harmful fore ign 
substances which form t h e luminal contents. The surface ep i t helium is t h e 
only barrier between the mucosa l blood vessels and this ever - c h a nging 
mixture of antigens and microorganisms. Henc e , to protect aga inst 
possible invasion, the mucosa of all parts of the alimentary t ract is 
heavily populated with immune cells. In fact, about one quarter of the 
mucosa is made up of lymphoid Lissue, which includes lymphat ic nodules 
(organized aggregates of l ymphoid cells), di spersed l ymphocytes and 
plasma cells in t he l amina propria, and intraepi thelial l ymphocytes which 
are wandering lymphocytes insinuated between epithelial cel ls. Such 
lymphoid tissue is collectivc>ly 1-eferred to as "Gut Associated Ly mpho id 
Tissue " (GALT) . In some areas of the small intestine, many lymphoid 
nodules can occur together in closely packed clusters, with the 
e pithel ium flattened over it. Such areas appear macroscopically as oval 
s haped b odies re f e rred to as "Peyer' s patches ". In t h e large intestine, 
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?eyer's patches are usually absent. In the human large intestine , ?eyer ' s 
patches can be found in the appendix (Neutra, 1988; Banks, 1993). 
The epithelial barrier is sometimes inadequate to protect against 
all a ntigens (even in healthy subjects) so that antigens occas ionally 
gain access to the intercel lular spaces. Such antigens are then sampl e d 
and processed by i ntraepithe lial lymphocytes, which a re usually in 
contact with a nearby macrophage. These lymphocytes are mostly T cells 
while some B cells are also present. Antigen sampling is thought to occur 
most efficiently in the flattened epithelium overlying lymphatic nodules 
such as in Peyer 's patches. ln such areas t here is a special type of 
e pi the lial cell called the "M cell" , whose apica l surface contains 
microfolds which can endocytose macromolecules. The endocytosed molecules 
are transported in vesicles to the intraepithelial lymphocytes which then 
migrate out of the epithelium to the lymphoid cell aggregates where B 
ce lls produce antibodies against the antigens. 
The most common type of im111unoglobulin produced by plasma cells in 
the lamina propria is secretory immunoglobulin A, which is dimeric. Other 
plasma cells produce p olymeric secretory immunoglobulin M. There is a 
specific vesicular carrier system in the crypt epithelial cells which 
deliver both IgA and IgM to intestinal secret ions. These antibodies then 
combine with luminal antigens (e 11Lerotoxins, microorganisms etc.) and 
protect the epithelial surface by "immune exc lusion". In the lamina 
propria, there are also smaller populat ions of plasma cells which produce 
the monomeric antibodies IgG and IgE. A function for these antibodies is 
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not clearly eluc idate d yet, and they are believed to diffuse into the 
lumen where they are degraded. (Neutra, 1988; Banks, 1993). 
Inf l amma tory Bowel Disease 
The term "Inflammatory bowel disease " (IBD) refers to a group of 
disorders affecting the intestine, c h aracterize d by chronic i nflammation 
with undefined et iology. In humans, IBD includes ulcerat ive colitis and 
Crohn ' s disease, which, although considered to be two sepa rate disease 
entities, share numerous clinical and pathological features so as to be 
somet imes indistinguishable. In addition, several other forms of 
intestinal inflammat ion of unspecified etiology fall into t his category , 
such as l ymphocytic col i t i s, col l agenous coli tis , pouchitis a nd diversion 
co li tis (Podolsky, 1991). 
TBD is charncrerized bv chronic diarrhea and microscopic mucosal 
inflammation with or without gross l esions. It has been difficul t to 
produce a clear and spec ific picture of its pathogenesis due to the 
comp l ex nature of the disease, its variable manifestations and the 
difficulty in reprodu c ing the disease in animal models due to its unknown 
etiology ( Po dolsky, 1991). However, there has been some success in 
experimentally reproducing at l0nst severa l features of IBD in some 
animal models by administration of exogenous agents, such as dextran 
sulfate which induces colitis in rodents (Okayasu et al., 1990) . Oth er 
anima l models which show some similar ity to human IBD are t h e 
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sponta n e ously d eveloping coli t i s in cotton top t a ma r in (Ma dar a et a l . , 
1985) a nd the e ndogenous b owe l inflamma tion in t r a nsgenic rats express ing 
huma n HLA - B27 a nd b eta macroglobul in (Hamme r et a l. , 1990). 
Etio l ogy 
Al thoug h t h e causat i ve agents have not b een s pec i f i c al l y 
i d e n t i f i e d, a number of f acto r s have been found to b e asso c iated with the 
inc ide nce of I BO. For example, evide nce o f g e net i c pre d ispos i t i on i s 
s uggested by t h e increased prevalence of the disease among fir s t degr ee 
r e l ations o f affected pat i ents, increased inc i dence i n certa in 
populations (Bennet et al., 1991), and the high rate of disease 
occ ur renc e in mo no z y got i c t wins of a f fecte d p a ti e n t s as o ppose d to 
dizygotic t wi ns ( Tys k et al., 1988). The nature of t h is ge n e t i c factor 
has n ot bee n identifie d , a nd i s s u s pected t o b e a n ab er r a nt ge n e whic h 
e n codes a f actor causing structural alterations in the gast ro - intes t inal 
tract. Ulcerative colitis has been found to be associated with t h e 
ap pea r ance of H serum ancineutrophil cytoplasmic antibody, whic h , whi le 
probably not direct l y involved in the pathogenesis of I BO, ma y b e useful 
as a mark e r (Duerr et al., 1991). 
Structura l a b normalities i n t h e gastro-intest i nal trac t are 
s us pected to pred i s pose to IBO by rendering t h e mucosa s u sceptible to 
d amag i ng agents (Delpre et al., 1989). Fo r example, abnorma l s truc t ures 
have been f ound in co l o n ic ep i thelia l ce ll s i n IBO (Gibso n e t a l . , 198 8 ) 
a nd t h e complex matr i x of mucin glycoproteins showed alterat ions s uch as 
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selec t ive reduction of one population of g l ycoproteins, which persists 
inde p e ndentl y of disease activity in ulcerative c olitis (Podolsky et al., 
1983; Podolsky et al., 1988) . Crohn's disease has bee n associated with 
increased intestinal permeability (O l a i s on et a l., 19 88). Some features 
of the disea se have been attributed to a granulomatous angii t i s causing 
isc h emic infarc ts (Wakefield et a l., 1989; Wake field et a l. , 1991). 
Althoug h infectious agents h ave been suspected to contribute to the 
initiation of t h e disord e r , ev i dence is inade quate to inc riminate any 
parti cula r organism . Mycobacterium paratuberculos is, the causat ive agent 
of Johne ' s di sease, h as b een i solated irom patients with Crohn' s disease, 
but the rates of i so1<1tion WE'l"f low nnct the same organism has been found 
in some con tro l pat i e n ts as well (Butch er et al . , 1988). Some 
investigators h ave suggested indirect invo l vement of a biological agent, 
with damage produced by a product (such as formylated peptides) from a 
non pathogenic or normal luminal bacteria. A c hronic granulomatou s 
intestina l inflammation h ad resulted from injection of proteogl ycans from 
bacterial cell wa ll s (Sartor ec al., 1989). 
Pathogenesis 
Regardless of the etiology, the pa thoge nesis o f IBD involves 
immunologi c mech a ni s ms, as suggested by ci r cumstant i al e vidence 
(Brandtzaeg et al., 1989). IBD mav be initiated by an alteration of the 
phys iolog i ca l inflamma tory response of the in testina l mucos a . The lamina 
propri a of the intestine and colon possess a continuously present 
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" physio l og i cal" inflammatory response, which is presumed to result fro m 
the continuous infl ux of antigens through the lumen . There are r egulatory 
mechanisms to prevent unrestrained act ivation of such immune and 
inflammatory r es ponses. Failure or inadequacy of t h ese regu latory 
mec hanisms, r esult ing in exaggerated inflammatory response, is suspected 
to predispose to IBD ( Podolsky, 1991). Numerous alterations in the 
general and mucosa l immune response have been found in IBD patients. 
These inc l ude c h a nges i n immune ce ll populations, compleme n t compone n ts 
and inflammatory mediators . 
Increases in IgG bearing ce ll s have been obse r ved in IBD pat i ents. 
This may re s ul t from altered h oming me c h a n isms or an altered pattern of 
cytok ine s whi c h contro l B celJ differenL iation (Hibi et al., 1990; 
MacDe rmot et a l., 1981 ) . The i ncrease in cel l numbers r esults in a 
general increase of the product ion of IgG as well as select ive inc r eases 
in specific subtypes i n bo t h blood a nd intestinal muc o sa (MacDermot et 
al., 1989). These IgG antibodies may be directed against one or several 
antigens. One such antigen is a 110 Kd protein present in co lonic tissue 
of both normal and di seased s ubj ects (Taka hn shi et al., 1985). 
Th e i mmune response c ould also be altered by changes i n i n test i n a l 
epithelial cells. Thi s i s suggested by a marke d reduction i n t h e 
induction of suppressor T ce l ls by intest ina l epith elial cells (Maye r et 
a l. , 1990). In Crohn's disease patien ts , elevated leve l s of cytotox i c 
Leu 7+ ce lls (a s ubg roup of CD8 t T ce l ls) in Lh e peripheral blood as wel l 
as in t he infla med mucosa h ave been observed (Cant r e ll et a l., 1990). 
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Increased numbers of intraepithel ial lymphocytes (Entrican et al., 1987) 
and foca l accumulations of leukocytes close to glandular c rypts (Schmitz-
Moorman et al., 1981) have been observed in ulcerative colitis and 
Crohn's disease . A prefe r ential accumulat ion of anti gen-pr imed me mory 
cells is suggested by a s i gnificant reduction in the proportion o f 
putative naive T cells in the intestinal mucosa and peripheral blood 
(Br andtzaeg et al. , 1989). A significant increase in T4 lymphocytes and a 
decrease in T8 lymphocyte s in the epithelium was observe d in IBO when 
compared co the normal colon (Kobayashi et al., 1988 ). 
In addition to changes in immune cel l popu l ations, t h e re i s 
deposition of complement components in the mucosa of patients with IBO 
(Ahrenstedc eL a l . , 1990) and a marked induction of express ion of major 
histocompatibilicy complex Class II antigens in intestinal epithelial 
cells, which suggests alteration in antigen presenting activity ( Mayer et 
al. , 1991). 
Several features of IBO suggest that mucosa l immune activation, 
such as a l teration in the expression of several types of cytokines and 
lymphokines, may play a significant role in the disease. Increased 
expression of the cytokines inLe rleukin-1 and interleukin-6 h as been 
noted, in addition to altered express i on of interleukin-2 and its 
receptor . Antigenic challenge leads to induction of interleukin-2 and its 
receptors in Crohn's disease, but the tissue levels were low as oppos ed 
to the circulflting soluble i nterleuk i n-2 levels (Ma hida et a l . , 1 989; 
Mahida et al., 1990; Kusugami Pt al.. 1989; Li gumsky et a l., 1990; 
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Crabt r ee et al., 1990). I n a rabbit model of colitis, the sev e r i ty of 
i nf l amma tion was red uced by administration of interleuk i n-1 r e c e ptor 
anta gonist ( Commine lli et a l . 1990). Oth e r fa c tor s that regu l ate 
i n t es t i na l immune/ inflammat or y r esp onses are l ike ly to b e peptide 
me diators o f loca l a nd systemic neuroendocrine f u n ction ( Shana h a n et a l ., 
1988). 
T i s s u e inj u ry may be produced by numerous n o ncytokin e i n fl a mmatory 
me diators whose product ion i s enhanced in I BO . Th ese i nc l ude e i cosanoid 
produc ts of a r achidon i c ac i d metabol i s m, such as prostagl a ndin a nd 
t hromboxa ne produ cts o f c yc l oxygenase and t hromboxan e synthetase ( Zi rfoni 
et a l., 1983). Th e inflammation may be furth e r ampl ified b y 5 -
lipoxyge n ase p roducts, pa r t i cularly leukotri e ne - 84 (Nielson e t a l . , 1987; 
Sh a r on et a l ., 1984). That these nonspecific i nflammatory medi a t o r s play 
a major role i n susta i ning the disease process is indicated b y the f act 
that most ava i lable therapeutic approaches to IBO work by inhibi t i n g 
t hese nons pecif i c path ways of inflammat i on. 
A path oge n ic mech a ni s m for IBO h as been proposed b y Brandtzaeg et 
al., 1989. T cells are attracted to the intestinal epithelium by the 
initiatin g event or events. The stimul ation of these T ce l ls and 
macroph ages l ead to r e l ease of cytokines, which i nduce ep i t h e l i a l HLA 
c l ass II e xpress ion . HLA c l ass II renders the e pi t h el ium vulne rable to 
pe netra tio n by l u mi na l ant i ge ns. The uptake a n d p r esentation of lumi na l 
antigens to mucosa l T cells induces "help" rath er than " suppr ess ion " . 
Th is mec h an i sm can be enhanced if luminal antigens get i n to t h e muc o sa 
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through a break in the epithelium. Endothelial receptor mechan i sms are 
altered by cytokines released fro1n stimulate d leukocytes. This results in 
attraction of B cells from the systemic immune system, which l eads to 
overproduction of I gGl and IgG2, and preferential production of monome ric 
lgAl. The immunologic homeostasis of the gut is changed by t hi s imbalance 
between secretory and systemic immunity, which enhances further 
inflammation and tissue damage. As a re sult of transudation from vessels 
or local production, IgG and comple1nent factors accumulate at the 
epithelial surface. Complement is acLivated due to immune complex 
formation, and this causes epithelial damage. Activated complement and 
immune complexes stimulate macrophages, which release biologically active 
substances like l eukotrienes and complement factors. They a l so mobi lize 
neutrophils which release lysosomal enzy1nes and oxygen radicals, whi c h 
damage the epithelium. Substances r~leased from macrophages can stimulate 
smooth muscles, leading to spastic contractions. They also bring about 
vasodilatation and increased vascular permeability. 
Increased numbers of inflammaLory cells such as neutrophils, 
lymphocytes, monocytes and mast cells are recruited to the intestinal 
mucosa in IBO. The mechanism whereby th i s occurs is no t clear, but may be 
due to cell adhesion t o endothelial surfaces with s ubsequent penetration 
into tissues. This is associated with Lhe expression of a specific 
endothe lial- cell-leukocyte-adhesion mo l ecule (Podolsky: unpublished data, 
cited in Podolsky 1991, p.931 ). This molecule may be induced by 
cytokines present in high concentration as a result of tissue injury. The 
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attraction of neutrophils to the mucosa may also b e mediated by 
chemotactic l e ukotrienes and formylated bacterial pep tides . The 
inflammatory cells, once activated by these inflammatory mediators, go on 
to produce more of the same me diato r s so t h at the situation becomes 
a u toamplify i ng, t h ereby generating the manifestations of infl ammatory 
bowe l d i sease. 
The chronic colonic inflammation thus brought about, leads t o 
disrup tion of the normal salt and water transport and alterat ion of the 
normal p attern of motility, which, in turn result in the chronic d i ar rhea 
that i s the cardinal clinical sign of IBD (Sherding & Burrows, 1992). 
In t h e normal colonic mucosa, there is a transmural potential 
difference r elated to active sodium transport, with the mucosal s i de 
negative to the serosa . In ulcerative colitis, there is a mark ed 
reduction in this potential difference, which results in the inabi l ity t o 
absorb sodium against an electrochemical gradien t, and an increase in the 
plasma to l umen sodium flux r ate . Th is leads to an increased leakiness of 
the mucosa and increase d levels of sodium in the lumen, which contrib u te 
to the diarrhea (Sherding and Burrows, 1992). 
There i s evidence that colonic inflammation disrupts normal coloni c 
motor function. Th e spontaneous and urecholine - stimu l ated contrac ti l e 
activity of the c olon was suppressed in periods of severe diarrhea i n 
cats wi th diffuse e xperimental colitis. During healing and regenerat i on , 
this contracti le activity was increased . Isolated colonic musc l e from 
cats with 0 idiopathic summer diarrhea'' showed a di s ruption of electr i cal 
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slow wave conduction, while there was significant derangement in t h e 
myoelectric characteristics of individual colonic muscle cel l s in dogs 
with ex pe rimental acute colitis. In human ulcerative colitis patients, a n 
overal l decrease in co l onic motor activity h as been observed including an 
abnormal response to food i ngestion. In such patients, the major 
abno r mal ity was found in smooth muscle cont r actility as opposed to 
relatively normal myoelectrical activity. This is evidence for a lack of 
coup l ing between the electrical and mechanical events. (She rding & 
Burrows, 1992). 
In summary, inflammatory bowel disease appears to stem from a 
failure in the colonic mucosal immune regulatory mechanisms which l eads 
to an uncontrolled and exaggerated in[lammatory response to the normal 
a n tigenic load. Chronic inflammation results in a disruption of t h e 
contracti le activity as well as Lhe salt and water transport mechanisms, 
which in turn leads to chronic diarrhea. 
Clinical and laboratory finding s 
Ulcerative colitis and Crohn's disease, being the two major forms 
of human IBO, show a number of similar clinical and histopathological 
features. But there are significant differences that distingu i sh each 
disease. Al though both diseases are characterized by chronic recurrent 
intestinal inflammat i on, in ulcerative colitis the inflammatory process 
usually starts from the rectum and extends proximally, being confined to 
the superficial layers of the bowel wall (mucosa and superficial 
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submucosa), whereas in Crohn ' s disease the inflammation involves the 
d eeper layers and may even spread Lransmurally. Both diseases are 
characterized by dense infiltration of inflammatory cells, whe r e the 
predominant cel l types are neutrophi l s and lymphocytes in ulcerative 
colitis, while macrophages and lymphocyte s predominate i n Crohn' s 
disease. In add i tion to the cellular infil t ration of the lami na propria, 
the main histopathological features in ulcerative co litis are format ion 
of microabscesses within the crypLs, depletion of mucin from goblet 
cells, and absence of inflammatio11 in Lhe deeper layers of the bowel 
wall. Extensive superficial ulceration i s characteristic, as opposed to 
the deep l inear ulcers seen in Crohn's disease. In the early stages of 
Crohn' s disease, dense areas of lymphoid tissue contain over l y ing 
aphthoid- l ike ulcers . As the disease progres ses , these u l cers spread deep 
into the underlying tissue in a fissure-like or serpiginous manner while 
the intervening tissue may be relatively preserved, which gives the 
mucosa a segmented or "cobblestone" appearance. This contrasts with the 
extensive and continuous superficial ulcers occurring in ulcerative 
colitis. These are macroscopical ly seen to be covered with a mucopurulent 
exudate. In about 50% of Crohn's disease patients, non-caseating 
granulomata develop due to aggregation of macrophages. Another common 
feature in Crohn ' s disease is collage n depos ition, which may lead to 
stricture formation. As i n ulcerative co li Lis, the most common areas 
involved in the inflammation are the term inal ileum and colon, but unlike 
ulcerative colitis , Crohn's disease can affect any site within the 
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alimentary tract and even extend beyond it by fistula formation. Anothe r 
distinguishing feature is that the rectum is rarely affected in Crohn's 
disease. Enterocutaneous fistulas often lead to perineal disease or 
"blind" sinus tract formation (Podolsky, 1991). 
In both diseases the prominent clinical feature is recurrent 
diarrhea, which is bloodstained in ulcerative coli tis owing to the 
extensive mucosa l ulceration. This is accompanied by abdomina l pain in 
Crohn' s disease due to inflammatory masses. Obstruction may occur in 
Crohn's disease due to severe inflammatory edema or stricture formation 
due to fibrosis. Bleeding is much lE>ss common in Crohn's disease than i n 
ulcerative colitis, while systemic signs like fever and weight loss are 
more common in Crohn's disease. Although the cardinal clinical symptom is 
diarrhea, constipation does sometimes occur in ulcerative colitis, 
probably due to disruption of peristaltic patterns (Podo l sky, 1991). 
Canine Inflammator y Bowel Disease 
As in humans, a number of poorly defined colonic diseases in dogs 
is collectively referred to as canine IBO. These diseases, whose 
pr i nciple feature is colonic inflammation causing chronic diarrhea, 
include plasmacytic lymphocytic col itis, eos inophilic colitis, 
granulomatous colitis and caninE> histiocytic ulcerative col itis. As the 
names imply, these forms are classified according to the nature of the 
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inflammatory infiltrate, there being no significant differences in the 
history or clinical picture ($herding & Burrows, 1992 ) . 
Like human IBD, canine IBO is b e lieved to stem from a defect i n the 
mucosal immunoregulation, whe r e a breach in the mucosa may lead to a self 
perpetuating, exaggerated immune r es ponse to bacterial or dietary 
proteins. Such inflammation may persist long after the inciting cause i s 
removed. The original cause might be anything that brings about mucosal 
injury, such as hookworm or whipworm infections (Sherding & Burrows, 
1992). 
Cases of canine IBD a r e usually presented with a history of chronic 
mucoid diarrhea, with poor response to conventional antidiarrheal 
therapy. Clinically, semiformed or liquid feces, often bloodstained and 
mucoid, are observed. The most frequently reported clinical symptoms a r e 
chronic diarrhea , vomition, weigh t loss and alteration of appetite. The 
region of the gastrointestinal tract affected and the extent of cellular 
infiltration determine the severity of these symptoms, which show a 
cyclic rather than progressive clinical course. Hematernesis and/or melena 
may occasionally occur due to severe ulceration of the intestinal mucosa . 
Symptoms of abdominal pain may occur but are less common (Jergens et a l . , 
1992). 
The etiopathogenesis is unk11own . One suspected cause is a 
hypersensitivity r eact ion to antigens in the bowe l lumen or mucosa. IBO 
is diagnosed by methodical e limina tion of other possible causes which 
produce similar symptoms, such as parasitic infections. Endoscopy and 
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histopath ological eva l uation of biopsy specimens are the main cr iteria 
fo r d i fferenti a l diagnosi s of var ious fo rms of IBD (Jerge ns et a l ., 
1992). 
Upon colonoscopy, t h e norma l mucosa appears as a smooth g l is t ening 
surface which reflects the e ndoscop i c ligh t uniformly. The mucosa i s 
translucent so that the superfic ial submucosal blood vessels are v i s ible. 
Th e normal pink co l or of the mucosa may or may not be changed b y 
hyperaemia depe nding o n the ty pe o f solution u sed for enema . Th e normal 
mucosa is somewhat flexibl e, distending readily upon air insuffl ation a nd 
not being damaged by rubbing with the tip of the endoscope (Sherding a nd 
Burrows, 1992). 
In IBD, t h e mucosa a ppears inflamed and edematous so that t h e 
s ubmucosal blood vessels are invisible. Irregular thickening of t h e 
mucosa causes a granular appearance in place of t he s mooth a nd glistening 
s urface in t h e normal bowel. Inflammation causes the mucosa to be fr i a ble 
s o tha t it will eas ily bleed when touched . There may b e ulceration in 
va r iable degrees and a thick tenacious mucus a dhering to the wall or free 
in the lumen . In granulomatous colit i s, severe mucosal proliferati on with 
granulomatous l es ions i s c haracteristic. This results in narrowin g o f t h e 
lumen a nd failure to dila te on air insufflation. Ulcera tion may occur , 
and the lesions a r e of a segmental nature with re lative l y norma l a r eas 
in terspersing with inflamed areas, and thus, this di sease is analogous to 
Crohn's disease in humans. Mul tiple strictures can also occur in 
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histiocytic ulcerative colitis, along with deep bleeding ulcers (Sherding 
and Burrows, 1992). 
Histological examination of mucosal biopsy specimens is the most 
reliable method of diagnosis of IBO . The histopath ological picture is 
s imilar in all forms o f canine IBO, and is characterized by mucosal 
thickening and edema, infil tration of inflammatory cells, depletion of 
goblet cells, and occasionally fibrosis of t he lamina propria caus ing the 
glands to be separated from each other. The inflammatory reaction may be 
acute or chronic, and focal or diffuse, depending on the stage and 
severity of the disease. Both acute and chronic reactions may appear in a 
single biopsy, indicating the progress ive nature of the disease (Sherding 
and Burrows, 1992). 
The different forms of canine IBD a re identified by a few 
d istinguishing histopathological features. For example, in granulomatous 
coli tis the inflammation i s of a segmental nature, with severe 
granulomatous pro l iferation of t he mucosa. Eosinophi l ic colitis is 
characterized by ci r culating eosinophil ia as well as h eavy mucosal 
infiltration of eosinophils. Infil tr~tion of PAS positive macrophages a nd 
progressive superficial ulceration are typical in histiocytic ulcerative 
colitis, whereas in plasmacytic l ymphocytic colitis the predominant cell 
types in the infiltrate are plasma cell s, lymphocytes, neutrophils a nd 
sometimes eosi nophil s (Sherding a nd Burrows, 1992). In addition to 
colonoscopy and histopathology, results of a hemogram may aid in the 
diagnosis. Frequent hematologi c fin dings in IBO are hypoalbuminemia, 
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h y p ergammaglobulinemia, and mild microcytic hypochromic anaemia caused b y 
persistent chroni c bleeding . Mild neutrophilia with a left shift may be 
seen i n l ymphocytic plas macytic coliti s , whi l e eosinophilic colitis is 
c h aracter iz ed by eos i nophilia and increased se rum IgE l e vels ( Sherding & 
Burrows, 1992). 
A r ecent study on cl i nical cases suggests there is no age, sex or 
breed predisposition for IBO , although previous studies have reported a 
higher inc idence in older animals. The same study has i ndicated a higher 
incidence among purebre d dogs (Jergens et al., 1992). 
Assoc iation o f I mmunog l obulin G with Inflammatory Bowel Disease 
The primary form of humeral im111unity in mammals is t he class of 
plasma protein referred to as immunoglobulins o r ant i bod i es . Th ese a re 
glycoprote in mo l ecules wi th a specific structure, synthesized a nd 
secreted in to the p l asma and tissue fluids by plasma cel l s ( B 
lymphocytes). While some i mmunoglobulins are produced at all times, most 
are synthesized only in response to antigenic stimulation, have a 
structure specif i ca lly complementary to t h e said antigen, and have the 
ability to inactivate the antigen by binding to i t . 
Immunoglobulins a re par t of the gamma -globulin fraction of plas ma 
prote ins. Al t h ou gh t h ey share a commo n basic structure, the re is a 
cons i derable degree of structural heterogenicity between different 
subclasses of immunoglobulins. The basic structural unit of an 
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immunoglobulin molecule is composed of two pairs of polypeptid e chains, 
namely the heavy chains and light chains, linked together by inte r cha in 
disulfide bonds . Each unit contains a fragment for antigen binding and 
ano t her fragment wh ich usually binds to a cell surface. (Sell, 1987). 
The main classes of immunoglobulins are immunoglobulin A ( I gA), 
immunoglobulin G (IgG), immunoglobulin M (IgM), imrnunoglobulin D (IgD) 
and immunoglobulin E (IgE). Each class, in turn, is divided into several 
subclasses. 
IgG, on which attention has been focused in this investigat ion , is 
the most abundant of the immunoglobulins. Its concentration i n the serum, 
which is around 1240 mg/dl, is significantly higher than the 
concentrations of other lg classes which range from 0.03 mg/dl (IgE) to 
270 mg/dl ( IgA). IgG is a monomer with a molecular weight of 150, 000, a 
sedimentation coefficient of 7, and a relatively long half life o f 2 3 
days. IgG is found in high concentrations in both vascular and 
ext r avascular spaces, and is able to cross the placental bar r ier. A 
specific property of IgG is the ability to fix complement, which is part 
of its protective mechanism. The function of IgG is to provide immunity 
against blood-borne infectious agents such as bacteria, viruses, 
parasites and fungi. It is also active in tissues, and receptors for IgG 
are found in human monocytes and lymphocytes. Hence, IgG can be 
considered to play a major part in providing protection within the body, 
as opposed to IgA which is the major immunoglobulin found in secre tions 
and mucosal surfaces which come into contact with the external 
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environment. Unlike IgA, IgG is noc known to play a significant role in 
the intestina l lumen, and is found only in trace amounts in normal 
subjects (Sel l, 198 7 ; Evans, 1984). 
The prote in level s in t h e intestinal lumen can b e qua ntified by 
testing whole gut lavage fluid (WGLF), which is the clear fluid passed 
following in itial colonic c leansing prior to procedures like endoscopy or 
su r gery. This fluid is a gut perfusate containing secreted proteins such 
as immunoglobulins. Although different types of proteins can normally b e 
found in gut lavage fluid, iL has been reported that IgG, albumin and 
a lpha-1 antitrypsin are found only in trace amounts in norma l subjects 
(Choudari et al. , 1993). In this study, gut lavage fluid was tested for 
the levels of t hese proteins in 45 hu1nan IBO patients. The results 
revealed that t h e levels of chese three proteins are markedly elevated in 
IBO, in proportion with the dis~ase activity. I gG showed the highest 
correlation with t h e disease activity . 
Previous studies by t h e same auth ors, using two separate g roups of 
IBO patients , have indicated t hat gut lavage IgG concentration s in I BO 
patients are significantly higher than t hose of controls (O 'Mahoney et 
al . , 1990; O'Mahoney et al., 1991), <lnd chat t here is a pos i t ive 
co rrelation betwee n secreted IgG levels and albumin l evels, suggest ing a 
leakage of proteins across the mucosa (O'Mahoney et al., 1991). Th i s 
study (Choudari et al., 1993) has revealed that e l evated levels of IgG, 
a lbumi n and alpha-1 antitrypsin (AlAT) are r elatively specific markers of 
active IBD, even though high levels are occasionally found in other forms 
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of colitis. However, rather than u se as screening tests for IBO i n 
general, these protein assays are more suitable for differentiation 
between active and inactive IBO, since the levels of these p r ote ins we r e 
foun d to be normal i n the i nactive disease. 
The source of I gG i n whole gut lavage fluid was init i a lly 
conside r ed to be t h e IgG bearing cells, as evidenced by an inc rea s e d 
number of these cells in IBO. An excess of IgG containing ce l ls l ocated 
deep in the mucosa of IBO patients were revealed by immunohistochemistry 
( Baklien et al., 1976; Saverymuttu el al., 1986) and high amounts of IgG 
were found to be secreted by isolated mononuclear cells from IBO pat i ents 
(MacOermott et al., 1981; Verspaget et al., 1988). Plasma ce l l IgG 
s ubclass d istribution was f ound to be different in IBO patien t s f r om t h a t 
of normal subjects (Kett et al .. 1987). However, r ecent studies have 
suggested that at least some of this IgG is derived from plasma r ather 
than cells in the mucosa (O'Mahoney et al., 1990; O'Mahoney et al., 1991; 
Choudari et al., 1993) evidenced by the positive correlation between IgG 
and albumin in the gut lavage from patients with active IBO. I n add i t i on , 
luminal concentrations of all three types of proteins were low in 
inactive Crohn's disease patients, even with extensive chroni c ulcers 
known to be rich in IgG bearing cells (Choudar i et al . , 1993) . 
The appearance of these proteins in the lumen may not be the me r e 
r esult of bleeding, since in active IBO the relative concentrat i o ns of 
each protein in WGLF significantly differed from those in plasma. 
Furthermore, a selective increase in the mucosa to lumen permeabi li ty f or 
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t h ese three proteins i s suggested by the fact t ha t the molecular weights 
of the three are not similar (IgG: 150 ,000 daltons, albumin: 69,000 
daltons and A1AT: 65,000 dnltons). One r eason for the albumin levels not 
being as hig h as the IgG l evels may be that albumin i s more s usceptib l e 
to proteolysis by intest inal enzymes prior to processing of the l avage 
fluid ( Chouda ri e t al., 1 993). 
There are several reasons to cons ide r gut lavage fluid protein 
quantification to be a bet ter approach for measurement of disease 
activi ty than other existing scientific approaches. Tests like 
e rythrocyte sedimentation rate (ESR), platelet count, acute phase 
proteins etc ., while useful, are not always rel i ab l e, s ince they may 
appear norma l in active IBO, and positive in inflammatory states without 
gut involvement. Techniques like labeled leukocyte studies involve 
exposure to radioactivity and reqt1ire complete fecal collection, in 
add i t i on to being expensive. The results of these tests are influe nced by 
concurrent dietary and pharmacological treaL1nents, while WGLF is not 
(Choudari et a l. , 1993). Gut lavage is a procedure widely used for bowel 
preparation for e ndoscopy, radiology and surgery , and the lavage fluid 
can be easily obtained in the course of the diagnostic and therapeutic 
procedure. Also this fluid can be stored for severa l months at -70°C 
without deterioration, and is aesthetical ly acce p tab l e and easy to 
ha ndle . The most impor tant factor is that IgG concentration s in gut 
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lavage fluid may distinguish between active and inactive IBO and 
accurate l y grade the degree of disease activity. 
Nitric Oxide: General Overview 
Ni tric oxide (NO) is a highly volatile gaseous compound synthesized 
from L- arginine by the enzyme nitric oxide synthase (NOS). NO has been 
found in tissues of t he nervous, immune and cardiovascular systems, and 
is believed to play a major regt1lncorv role as a physiologic messenge r 
molecule. NO is also suspectE:'d to bE:' involved in the pathophys iology of 
various conditions such as neurodegenerative diseases, septic shock, 
hype rte nsion and str oke (Brede & Snyder, 1994). 
Nitric oxide synthase (NOS) has been isolated and purified from a 
number of tissues including the brain, macrophages and vascular 
endothelium, and its structurt> .-111d [unction have been elucidated by 
molecular cloning of the cDNA. Each isoform of NOS has been named 
according to the tissue from which it was isolated, name l y bNOS (brain 
NOS), macNOS (macrophage NOS), eNOS (endothe lial NOS) and nonmacrophage 
inducible NOS (Schmidt et al., 1991; Mayer et al., 1990; Yui et al., 
1991; Stuehr et al., 1991; Hevel et al., 1991; Evans et al., 1992; 
Pollock et al., 1991; Brede el nl., 1990, 1991; Nakane et al., 1991; 
Lamas et al., 1992; Sessa et al., 1992: Janssens et al., 1992; Xie et 
al., 1992; Lyons et al., 1992; Lowenstein et al., 1992; Gel ler et al., 
1993). 
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Function of nitric oxide synthase 
The subs tra te f o r NOS is L-argini ne , whos e gua nidine group is 
oxidized in a process consuming fi ve elec t r ons, resulting in the 
formation of NO and L-citrulline (Figure 1). 
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Figure 1. Biosynthesis of nitric oxide. Nitric oxide and L-citrulline 
are the end products of the oxidation reaction of L-arginine, 
catalyzed by nitric oxide s ynthase. The reaction involves the 
intermediate L-hydroxy-arginine, which is tightly bound to the 
enzyme . 
This r eaction can be inhibited by s truc tural analogs of L-arginine 
such as L-Nw-substituted arginines . Although simultaneous application of 
L-arginine initially reverses this inhibition, some of these agents can 
caus e irreve r s ible inhibition o f NOS upon pro l onged exposure . The 
sensit i vity to these inhibitors differ slightly among d i ffe r e n t i s oforms 
of NOS . The b r ain and endothelial NOS are most potently inhib ited by L-
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NNA while the most potent inhibiter f or macNOS is L- Nw aminoarginine (L-
NAA). (Pufahl et al., 1992; Fe ldma n et al., 1993; Moore et al., 1993). 
NOS has close homology with the enzyme cytochrome P450 reductase (CPR) 
and employs fi v e redox act i ve cof actors including NADPH, FAD and FMN 
( Heve l et al . , 1991; Bredt et al., 199 1). The mechani sm of action of CPR 
where reducing equival e nts a r e relayed from NADPH to heme-containing 
cytochrome P450 e nz ymes, i s thought to be share d by NOS. Ev idence for 
this is that each NOS monomer in b NOS and macNOS c ontains one equivalent 
of iron-protoporphy rin IX ( McM illan et a l., 1992; White et al., 1992; 
Stueh r et al., 1992). Th e invo l vement of a cytoch rome P450 type heme is 
also suggested by t h e i nhibition o [ puri f i e d NOS by carbon monoxide. NOS 
is feedback inhibited by NO, whic h migh t interact with t h e heme 
prosthetic group of NOS. Arg i n i ne, the substrate of NOS, also binds to 
the heme prosthetic group ini t i ally, as do t he s ubstrates of various 
cytochrome P450 e nzymes (Renga samy et al., 1993 ; Assreuy et al., 1993; 
Rogers et al., 1992; McMill a n et al., 1993). One difference be tween NOS 
and othe r mamma lia n cytochrome P450 enzymes is t hat NOS is not an 
i ntegra l membra ne pro te in, and its flavin and h e me-conta ining domains are 
fused in a single polypeptide (Narhi et a l ., 1986). NOS r e quires 
tetrahydrobiopte rin ( H4 B) f or its act i v i ty . H4B is believed to stabilize 
NOS, as it does not affect the initial rate of NOS and is not recycled 
(G i ovanel li et al., 199 1 ). 
The conversion o f a r g inine to NO occurs in two distinct steps. The 
first ste p is the oxidation of a r ginine to Nw- hydroxyarginine (NHA) by 
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removal of two electrons. This intermediate is usually tightly bound to 
the enzyme. This h ydroxylation step utilizes 1 eq of NADPH a nd 1 eq of 
02 , as do the c l ass ical P450 type monooxygenation reactions. The reaction 
requires calcium and calmodulin as act ivators. It is accelerated by H4B 
and blocked by CO ( Klatt et al., 1993; White et al., 1992; Stuehr et al., 
1991). 
The second step where NHA is converted to NO and citrulline is not 
fully elucidated. The known facts about this reaction are that it 
utilizes 0.5 eq NADPH, require s calcium/calmodulin, is accelerated b y H4B 
and is inhibited by carbon monoxide and argin ine analogs (Klatt et al., 
1993; White et al . , 1992; Stuehr et nl., 1991). 
Regulation of nitric oxide synthase 
The brain and endothe lial NOSs, be ing calmodul in activated enzymes, 
require ca lcium as a major regulator. Calcium ion (Ca++) binds to 
calmodulin and thereby activates NOS. For each isoform of NOS, ca++ 
becomes available by a different mechanism. For example in t he brain, 
glutamate acting on NMDA receptors triggers ca++ influx, while in 
endothe lial cells ca++ is generated by the phosphoinositide cyc l e 
activated by acetylcholine b inding to muscarinic r eceptors. The electron 
transfer and oxygen activation of NOS are regulated by calcium and 
calmodulin, while the arginine binding is not (Klatt et al., 1993; 
McMillan et al. , 1993; Pou et a l .. 1992). Calmodulin antagon ists such as 
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trifluoperazin e inhibit the brain and endothelial NOSs (Bredt et al., 
1990). 
While the macrophage and n onmac r ophage inducible NOSs are not 
r egula ted by calcium or calmodul i n, they do possess calmodulin 
recogn i t i on sites. Calmodulin binds very tightly to t hese s ites 
unaffected b y ca lcium , unlike neurona l NOS whose binding to calmodul i n is 
dependent on the presence o f calcium (Cho e t al., 1992; Nathan , 1992). 
Th e inducible form of NOS was first detected i n mac rophages which , 
in r esponse to stimulation by in terferon-gamma a nd lipopo l ysaccharide 
(LPS), synth es i zed new NOS prote i ns over 2-4 hours. Such NOS pro te ins 
were not detectable without st i mulation (Nathan 1992). Apart from 
macrophages, numerous other tissues have shown inducible NOS act ivity in 
response to endotoxin treatment. Th e hepatocyte-inducible NOS is 
considered t o be the main fo r m of nonmac r ophage-induc ible NOS (Ge l ler et 
al., 1993). 
Another regulatory mechanism of NOS is phosphorylation. Brain, 
endothelial and hep atic- i nducible forms of NOS possess consensus 
sequences fo r phosphorylation by cAM P dependent protein kinase. Such 
sequences are not obvious in macNOS. Neuronal NOS can b e p h osphorylated 
by several kinases such as cAMP dependent protein k inase, cGMP dependent 
protein kinase , protein kinase C, and Ca++/calmodulin dependent p r otein 
kinase. Ph osph orylat ion by each of t h ese kinases r esults in decreased 
catalytic activity. Enzyme regulation occurs at multiple levels, such as 
direct enzyme activation by Ca 1 +/calmodulin and inhibi tion of enzyme 
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activity through phosphory l ation by ca ++;calmodulin dependent protein 
kinase ( Bred t et a l ., 1992; Nakane et al. , 1991 ; Brune et a l., 1991). 
In addition to enzymatic activity, s ubcellular di stribution o f eNOS 
is also regula ted by phosphorylation. This enzyme which i s predominantl y 
localized in the plasma me mbrane (unlike bNOS and macNOS which are 
cytosolic) translocates to the soluble fractions upon phos phorylat i on in 
response to bra dy kinin. Thi s cytosol i c eNOS being catalytically inactive, 
NO i s not generated within t h e endothel ial ce ll. It is the non 
phosphorylated NOS in the plasma membrane t hat generates NO, which i s 
relea sed into t h e extrace llula r e nvironment. This may be true for 
neuronal NOS as we ll ( Polloc k et al., 1991: Mich e l et al. , 1993; Hiki et 
al., 1992). 
Neuronal functions of nitric oxide 
The main functi on o f NO in t he nervous system i s believed to be 
neurotran smission. Using t h e technique of immunohistochemical staining, 
it ha s bee n discovered that throughout t h e central nervous sys tem, NOS 
occurs only in ne urons. Although NOS containi ng neurons represent a small 
perce n tage of total n e urons, rhev are wide l y distributed in t h e central 
nervous system (Brede et al., 1990 ). 
The syn thes i s of NO is bel i eved to b e triggered through stimulation 
of NMDA receptors by glutamate and s imilar s ubstances. Thi s NO in turn 
activates guanylate cyclase (GC) , which may b e the principle ta rge t 
t hrough which NO exerts i ts actio11. That NO may have other targets than 
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GC, and that other neurotransm i tters besides NO may regulate GC, is 
indicated b y the markedly differing localizations of GC and NO (Brede and 
Snyder, 1994). NO, through the activation of GC , ge ne ra tes cGMP, whose 
exact function is as yet unclear. However, a variety of actions exerted 
by cGMP have b een discovered, such as the act ivat ion of a 
serine/ threonine protein kinas e which is selectively expressed in the 
cerebellar purkinje cells (Lohmann et al., 1981), r egulation of ion 
channels in visual and olfactory tissue (Nakamura et al., 1987) , and 
modulation of cAM P signalling by regulating the activity of certain cAMP 
phosphodiester ases (Peunova et al., 1993). There i s evid ence t h at NO 
enhances neurotransmitter release, since NOS inhibito r s such as 
nitroarginine block neuro trans mi tter release (Zhu et a l ., 1 992 ). Further 
evidence of this effect comes fro1n a system using PC12 cells which 
develop neuronal properties in the presence of nerve growth factor. In 
t h ese cel l s, NOS staining and NOS catalyt ic activity (wh i ch is normally 
absent) appea r s after eight days of nerve growth factor application . At 
the same time, a marked enhancement of acetylcholine release in response 
to depolarization was observed, and t hi s effect was block ed by NOS 
inhibitors a nd reversed by excess L-arginine ( Hirsch et al., 1993; cited 
in Bre de and Snyder, 1 994, pp .185-186). 
Nitric ox ide may also influence the differentiation and 
regeneration of neurons. There is transient expression of bNOS throughout 
the embryonic nervous system and following neuronal injury, a lthough the 
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precise role played by NO in these s i tuat ions is not clear (Bredt and 
Snyder, 1994). 
The neurotransmitter function of NO is relatively clear in the 
autonomic nervous system. Myenteric ple xus in the gastrointestinal 
pathway contain many NOS neurons (Bredt et al., 1990). The relaxation of 
smooth muscle which results from depolarization of the myenteric plexus 
is blocked by NOS inhibitors, indicating that NO is a neurotransmitter in 
this situation ( Desai et al .. 1991). 
Similar experiments have revealed NO to be the autonomic 
neurotransmitter in several other tissues such as the advent itial layers 
of large blood vessels (Bredt et al., 1990), the pelvic plexus and 
cavernous nerve of penile tissue (Burnett et a l., 1992), gangl ion cells 
and fibers in the adrenal medulla (BredL et al., 1990) , and macula densa 
of the kidney (Wi lcox et al., 1992). In s pite of its physiological role 
in the nervous system, excess NO can be neurotoxic. In n e urodegenerative 
diseases like Alzheimers disease and Huntingdon ' s disease, and in the 
focal ischemia of vascular stroke, t h e neurotoxicity is mediated by 
excess glutamate acting at NMOA receptors (Choi 1988) . Excess NMDA 
receptor stimulation does nol destroy the NOS neurons, as these neurons 
are resistant to the NMDA induced damage (Dawson et al., 1993). He nce, 
excess NMDA st imulation would result in the release of excess NO, which 
is b e lieved to damage other neurons. In cerebral cortical cultures, 60 -
90% of the neurons die upon exposure to NMDA while NOS neurons remain 
undamaged. This damage can be blocked by treatment with NOS inhibitors, 
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re mova l of a r ginine from the medi um, or scavenging NO using hemoglobin, 
wh ich i n d i ca t es that t h e primary damagi n g agen t may be NO (Dawson et a l., 
1 99 3; Koh et a l. , 1 986; Ko h et a l. , 1988; Dawson et al., 1991 ). 
Immune functions of nitric oxide 
Th e primary role of NO i n macro phages is protect i on, which involves 
t h e mediat ion o f b actericidal and tumorici dal actions o f mac rophages in 
r esponse to i nflamma t ory stimu li like endotox in . Such stimul i, i nc l uding 
i nte r feron- gamma, factor-a l pha, in te rleuk in-1, and l ipopolysaccharide, 
are r esponsible fo r syn thesis of large amou n ts macNOS from negl i g ible 
basa l leve l s. Th e tumo r icidal and bactericidal activity i n mac rophage 
c ul t u res can b e b l ocke d by NOS i nhib i tors or remova l of arginine, 
indicating t h at NO is likely to b e r es ponsib l e fo r t h is activity ( Hibbs 
et al., 1987; Nathan , 1992) . Another poss ib le protective funct ion o f NO 
is i nhibition of vi r a l repl i cat ion , ns indicated by the l owe r i ng o f vira l 
ti t ers in cel l c ul tur es upo n addition of NOS, a n d elevation o f Coxs ackie 
v ira l t ite rs i n i n tact r ats upon administration o f NOS inh i bitors 
( Lowenstein et al ., 1993, cited in Bredt a nd Snyder, 1994; Ka rupiah et 
al., 1993). 
Cardiovascular f un c tion s of ni t r ic ox i de 
The main sub stance responsible f or e ndoge nous vasodilatation is 
bel i eved to be NO . Endothe lial NOS is activated by a n i nflux o f cal cium 
(which binds to calmo dul in) triggered by the action of a vasodila tor 
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agent (such as acety lcholine or bradykinin ) at the endoth el ia l ce l l 
r eceptors. Th e NO thus synLhesized, activates GC in the adjacent smooth 
muscle cells. The GC in turn caLalyzes the synthesis of cGMP, which 
brings about the relaxation of s mooth muscl e possib l y cilrough activation 
of cGMP - dependent prote i n kinase and phosphory lation of myosin l i ght 
chains (Bredt and Snyder , 1994 ). 
The hypotension in sept i c shock i s t hou ght to be mediated by NO , as 
e vidence d by the r eversal of hyp0Lensio11 upon administration of NOS 
inhibitors (Kilbourn et al., 1990; Hotchkiss et al., 1992). I n isch emi c 
cardiovascular conditions NO may play a protective role (mechanism 
unknown) as indicated by the r e duction of myocardial infarct size a nd 
decrease of mor tality in i sch emia and reperfusion of splanchnic ar t e r y 
upon administration of NO donor s (Siegfried et a l., 1992; Carey et al . , 
1992). 
NO can inhibit platelPt ag~regat ion and adhesion by mechanis ms 
which are unclear, but wh ich may involve effects on GC, phospholipase C 
or ADP r ibosylation (Durante et al., 1992; Zhang et al . , 1992) . 
Mechanism of a ction of ni t ri c ox i de 
A major compound binding site of NO is iron, both heme and non-
heme. The action of NO on many enzymes is mediated by binding to t h e iron 
in the enzyme. For example in GC, NO binds to the iron in heme at the 
ac tive site, which alters the enzyme ' s conformation and augments 
catalysis. In sever al other enzymes s uch as NADH-ubiquinone 
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ox idoreductase, NADH :succinate oxidoreductase, cis - aconitase and iron-
sulfur e nzymes, NO binds to non-heme i ron (Nath an, 1992; Bredt a nd 
Snyder,1994). By b i nding to the non-h eme iron of ribonu cleotide 
reductase, NO inhibi ts DNA synthesis (Kwon et al., 1991). The i ron in 
ferritin can a l so be bound by NO, resulting in the l iberation of t he iron 
and l ipid perox idation (Reif et al. , 1990). Other known mech an isms of NO 
are S-n i trosylation of numerous proteins ( Lipton et al., 1993) , and 
incorporation of NAO into g l yceraldehyde 3-phosphate dehydrogenase 
thereby inhibi ting its activity and depressing glyco l ysis (Zhang et a l . , 
1992). 
NO, be i ng a free radical, can damage DNA by base deam ination, which 
is the main mechan i sm of NO neurotoxicity (Zh ang et a l., 1 993 ; Wink et 
al . , 1991). DNA t h us damaged leads to poly - ADP - ribosylation of nuc lear 
proteins, thereby depleting NAO f r om the cell. Resynthesizing NAD 
requires very large amounts of ATP. Thi s process cont inues unt i l the cell 
dies from energy depletion ( Zha1 1g E' L <il., 1993) . 
Nitric Oxide Associate d with the Intestine 
The principl e known fun ct ion of NO in the mammalian i ntest ine is 
t h at of an inhibitory neurotransmitter/neuromodu l ator in the enter i c 
nervous system. NO is release d from the non-adrenergic non-chol ine rgic 
(NANC) nerve endings in the gut wal l (a nd in blood vessels), and acts as 
a smooth musc l e relaxant. While application of NO mimics the responses to 
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NANC inhibitory nerve stimulation, NOS inhib i tors reduce electrical l y 
evoked NANC me diated relaxation . Also, scavenging of NO using 
oxyhemoglobin inhibits the effects of both NANC stimulation and 
externally applied NO. (Nichol s et al . , 1993). 
A basic histochemical tec h n ique involving the reduction of a 
tetrazolium dye in the presence of NADPH has been used to reveal t h e 
catalytic activity of constitu tive NOS and thereby examine its 
distribution in t h e intestine. Such studies in rat and guinea pig 
intestines have shown NOS activity to be localized in subpopulations of 
neurons and nerve fibers throughout the gut wall nerve networks and i n 
enteric blood vessels (Nichols et al., 1993). 
Apart from the neuronal cel l s and vascular endothe lial cells, 
another important site of NOS act i vity (relevant to our study) is t h e 
intestinal epithelium. A study by Tepperma n et al., 1993, demonstrated 
the presence o f both co nstitutive and inducible forms of NOS in i so l ated 
e pithel i a l cells fro m rat sma ll inLest ine. The highest l eve l s of both 
forms of the enzyme were found in vi l lus cel l s . 
The role of NO in t h e intest inal epithelium is believed to be 
physiological r egulation of epithe lial cel l integrity and secretion . 
Acute microv ascular a nd e pi thelial cell damage in rat smal l intestin e was 
found to be exacerb ated by in travenous administration of a NOS inh ibitor 
(L-NMMA), which effect was prevented by concurre nt administration of a NO 
donor (S-nit roso-N - acetyl -penici ll amine) (Tepperman et al., 1993). In t h e 
feline small intestine, NO has been f ound to modulate e pithelial 
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permeability. In this study, local i ntra - a rt e rial infusio n of a NOS 
inhibitor resulted in a sixfold inc r ea se in mucosal permeability, and 
t hi s effect was comp l e t e l y r e v e r sed upon infusion of a NO dono r (Kubes , 
1 992). 
The role of NO in mo d u l a ting intes tinal epithelia l p e rmea b ility i s 
partic ular l y r e levant in inflammatory b owe l disease , s ince IBO is 
charac t e rized b y increased mic rovascula r p e rmeability and mucosa l barrie r 
dysfun c tion. The me cha ni s m t hat initial l y brings abou t muc osal l eakiness 
i s unc l ea r , and va r ious agent s s u c h a s reactive oxyge n metabolites, 
vasoconges ti o n and va scu l a r l e ukocytes h ave bee n suspec ted as poten t ia l 
mediators . Se v e r a l s tudi es h~ve prov i d e d e vide nce to b e l i eve t h a t NO may 
play a signifi cant r ole in intest ina l infl a mmatio n . 
In a cute inte stina l infl ammation , NO s eems to p l ay a protect i ve 
ro l e as h as b een r e v ea l e d in studies b y Aoki e t a l. , 1990 , Hu t c h e son et 
a l., 1990, a n d Kubes, 1992. Exo genous ly a dministe r e d NO was b e n e fi c ia l in 
isc h emia /rep e rfus ion of the in t es t i ne ( Aok i et a l. , 1 990 ), a nd NOS 
inhibitors inc luding N- monomethyl - L - a r g i ni ne exace rbated d a mage to the 
intes t ine in e ndotoxic s h oc k. That NO may pl ay a rol e in ma inta ining 
integr i t y in t h e norma l i ntestine was s uggested in the study by Kubes 
1992 , whe r e a u to p e rfused segme nts of cat ile u m we r e subjected to local 
intra - a r te r ial i nfus i o n of t h e NOS inhib i tor Ng - n itro-L-ar g i n i ne- me thyl 
ester ( L- NAM E) f o r 90 mi nu tes, wi t h co ncurre n t admini stra t ion o f a a n 
exo genou s NO donor, s odium n i t r o pruss ide ( SNP ) o nly d uring t h e l a st 30 
minu tes . Qu a n t i f i cat i o n of e p i t h e l ia l pe r me a b i l ity b y b lood to lume n 
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clearance of 51Cr labeled EDTA throughout the period revealed an increase 
in p ermeabi li ty of a pproximately six times the original level on infusion 
of L-NAME. This effect was completely reversed by SNP, the NO d onor. A 
later study by Kubes and Payne, 1993, revealed that reperfusion- induced 
increase in intestinal mucosal permeability can be reduced by NO donors. 
A 1 hour intestinal i schemia/reperfusion model of feline smal l i ntestine 
was us ed in this study, and the mucosal barrier integrity was asses sed 
using blood-to-lumen 51Cr EDTA clearance . Another parameter measured in 
this study was intestinal blood flow and resistance, in order to test 
whether the effect of NO is mediated through alteration in blood fl ow . 
The mucosal permeability was found to be significantly increased on 
reperfusion after 1 hour of ische1nia, and was accompanied by a 50% 
reduction in the intestinal blood flow. This mucosal barrier dysfunction 
was reduced by exogenous sources of NO and/or exogenous L-arginine, which 
did not have any effect on the blood flow. Administration of L-NAME 
worsened the mucosal barrier dysfunction and further increased the 
permeability . A significant improvement of the in testinal blood flow was 
observed upon add i t ion of 8-bromoguanosine 3' ,5 ' -cyclic monophosphate 
which is a permeable analogue of guanosine 3' ,5'-cyclic monophosphate. 
However, t hi s compound did not produce any change in the mucosa l 
permeability. The main conclusion of this study was that mucosa l barrier 
disruption induced by reperfusion can be reduced by exogenous sources of 
NO, independent of alterations in intestinal blood flow. 
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Al l of the abovementioned studies indicate that NO plays a 
protective role i n t h e intestine both in the normal situation a nd in 
acute i nj ury. Surprisingly, the effect of NO in chronic bowel 
inflammatio n appears to be the exact opposite, as revealed by the 
following studies . The effects of NO in c hronic inflammato ry bowe l 
disease were investigated in a guinea pig model of chronic ileitis 
induced by intraluminal administration of trinit robenzenesulfonic ac id 
(TNBS) (Mil l er et al., 1992). The animals with TNBS induced ileitis (as 
opposed to the s h am operated controls) were divided into two g roups . One 
group was treated with oral L-NAME, and another g roup with D-NAME (the 
inactive enantiomer of L-NAME) , while the remaining group was not treated 
with NOS inhibitors . Lwninal nitrite and protein l evels were measured and 
the i nflammatory r eaction was monitored over a 30 day period. The animal s 
with TNBS-induced chronic ileitis showed a significant inflammatory 
reaction characterized by cellular infiltration, mucosal thickening and 
elevation of myeloperoxidase activity . There was significant mucosa l 
leakage of protein and ni trite, while the mucosa was in a net secretory 
state as opposed to the net absorptive state observed in the normal 
intestine. Such changes were much less in the L-NAME treated group but 
not in the 0- NAME treated group, indicating that inhibition of NO 
synthesis may be benef i cial in chronic inflammation. In fact, treatment 
with L- NAME actually reversed the secretory state of the mucosa to t h e 
absorptive state . The endogenous NO production was apparently e l evated in 
proportion to the inflammatory reaction, as indicated by the elevated 
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n itri te levels in the lavage samples from the TNBS i l e i t i s g roup and t h e 
D-NAME treated group as opposed to the sham ope r ated controls and t h e L-
NAME treated group . Protein concentration s in the l avage fluid showed a 
five-fold inc rea s e in the TNBS group, suggest ing a s i gni ficant disrupt i on 
of the mucosal barrier during the i nflammation. 
Apart fro m such experimental models, elevation of luminal nitrite 
levels and mucosal barrier di s rup tion leading to pro tein l eakage are 
c h aracteristic findings in clinical cases of chronic inflammatory bowe l 
dis ease in huma n s (Roediger et a l., 1986 ; Choudari et al. , 1993). Upon 
measurement of nitrite l evels in rectal dial ysates in human subjects, 
lumi na l nitrite levels were significantly elevated in patients with acu te 
ulcerative coliti s as opposed to t h e immeasurable levels in control 
sub jects and quiescent colitis patients. 
One purpose of our study was to invest i gate wh ether t h ere i s a 
similar relationship b etween NO and c hronic intestinal i nfla mma t ion i n 
canine patients. To d etermin e whethe r intestinal epithel i al NO synth es i s 
is increased in can ine inf lammatory bowe l disease, colonic lavage nitr i te 
levels were measured i n IBO pat i ents and h ea lthy controls. 
As sessment of Disease Act ivity 
The principl e criterion us e d in this investigat i on to d etermine t h e 
presence and degree of IBD was hi stopa tho log i cal examinat ion of colonic 
biopsy specimens of each anima l. Specimens wer e examined for c lassic 
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signs of chronic inflammation such as ce llular infiltration and fibrosis. 
In addition, the activity of neutrophil myeloperoxidase was measured as a 
possible marker of disease activity. 
Myeloperoxidase (MPO) i s a neutrophil enzyme whose funct ion i s to 
convert hydrogen peroxide to hypohalous acids. Hydrogen p e roxide is one 
of the end products of the respiratory reactions of phagocytes and it is 
formed by free oxygen radicals reacting with themselves. The hypohalous 
acid produced by neutrophil MPO is hypochlorous acid (HOCl), the funct ion 
of which is to kil l microbes (Powell, 1988). 
Since this enzyme is predominantly localized in neutrophi l s, its 
activity can be used as a ma rke r for the neutrophil quantity of a given 
site. Most infl ammatory reactions, including human IBD, are character ized 
by neutrophilic infiltration. MPO activity has been us e d to assess the 
degree of inflammatory activity in several previous studies (Mil ler et 
al. , 1991; Miller et al., 1992; Bradley et al., 1982). 
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MATERIALS AND METHODS 
Animal s 
Con t r o l g r oup: Nine apparently hea lthy dogs with weight s r a nging 
from 36 to 43 pounds were obtained fro m Laboratory Animal Resources, 
Coll ege of Veterinary Medicine.Iowa State Unive rsity. There was no 
specific selection for breed or sex, and the g roup c onsisted of fo u r 
males a nd fi ve females of varying breeds, 11ame l y 1 Co llie, 1 Chow , 1 
Pointer, 1 German Shepherd, 1 Labrador, l Spaniel cross, 1 Greyhound and 
2 mongrels. 
Test gr oup: Ten dogs presented to the I SU Small An imal Hosp i ta l 
over a period o f one yea r (from August 1993 to Septe mb e r 1994) were used 
as test a nimals. These dogs came with a hi story of c h ron i c d i arrhea a n d 
weight loss. Upon clinical and laboratory examination IBO was suspected, 
and endoscopy and mucosal biopsy wer~ performed as further diagnostic 
procedures. For convenience in i dentification, t hese dogs wi l l b e 
referred to using numbers from Tl Lo TlO. 
Tl: A 4 yea r old female of Mix e d breed, presented with a his tory of 
c h ronic inte rmi ttent diarrhea and weight loss fo r 2-3 months. Clinical 
exami nat ion r evea l e d a thickened descend ing co lon and i r regular 
rough e ning of t h e rectum. Watery and mucoi d stools with o ccas iona l 
bloodstaining had been ob served. recal examination revealed whipworm 
eggs. Small intestinal diarrhea wi th seconda r y coli tis was suspected . The 
patient was wormed, and subsequent fecal tests were negative for parasite 
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ova. Diarrhea had continued since this treatment. Dietary therapy wi th a 
hypoallergenic diet 1 and enteric antibiotics produced no improvement. 
Subsequent feeding of a di fferent type of hypoallergenic diet and 
treatment with metronidazole (antigiardial drug) had brought about some 
imp rovement. 
T2: A 3 year old male Terrier, presented with chronic diarrhea , 
weight loss and vomition. Feces had been observed to be soft and forme d , 
and sometimes stained with fresh blood. Large bowel disease was 
suspected. 
T3: A 21/2 year old femal e Dob e rman, presented with c hronic 
diarrhea, vomition and weight loss through a period of 4 months . She had 
been treated previously with a hypoallergenic diet and metronidazo l e . The 
symptoms had subsided upon this treatment, and recurred following 
attempts to r eturn to an ordinary diet . Appetite was poor at the time o f 
presentation. 
T4: A one year old female of Mixed breed, was presented wi th a 
history of intermittent vomition and diarrhea . The feces were very watery 
and occasionally bloodstained . The vomiting usually preceded the onset of 
diarrhea, and the vomitus was ye l lowish white in color . Appetite had 
decreased gradually. 
TS: A 5 year old mal e English Pointer presented with a history of 
diarrhea and weight loss. The stools were watery, mucoid and sometimes 
bloodstained . The appetite was good. Large bowel dis ease was suspected. 
1 I / D Canned food: Mills Pet Nutrition Inc. Topeka, Kansas. 
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T6: An eight year old female Beagle presented with a h i stor y of 
chronic diarrhea, tenesmus, hematochezia a nd urgency of defecation. An 
acute onset of vomition had started a week prior to presentation . There 
was pain on abdominal palpation. 
T7: A six yea r o l d male Charpei, pres e nted with a history of 
vomi tion and diarrhea which had started about four weeks prior to 
admi ss i on. The vomi tus had initially been yellow with no food, then 
contained food and mucus , a nd gra dual l y become foamy and bloodstained . 
The feces had been initially yellow, and had later become dark and ta r ry , 
with higher frequency of defecation. Roundworm eggs had been detected in 
the feces. Previous treatment with antiparasitics and bismuth sal t s 
(mucosal protectant) had brought no improvement in the vomition and 
d i arrhea. The dog was anorecti c for ten days prior to presentation, a nd 
had lost e ight pounds in t h e past month. 
T8: A six year old male of mix e d breed, was admitted with a h i s tory 
of b l oodstained stools which had started two months prior to 
presentation. There had been no diarrhea , but fresh blood was obser ved 
after defecation. Vomition had occurred occasionally. Appetite was 
normal. He had been treated with metronidazole for one month, and b l ood 
in the feces had not been obs erved in the seven days prior to admission . 
T9: A nine year old mal e Cocker spaniel, presented with a history 
of chronic colitis of six months duration . Clinical history included 
tenesmus and large bowel diarrhea with mucus and fresh blood . Treatment 
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with sulfasalazine and corticosteroids for two months prior to admiss i on 
had not been effective. 
TlO: A twelve year old male o[ mixed breed, was admitted with a 
history of intermittent diarrhea of five months' duration. There had been 
no vomition or weight loss, but the animal had been lethargic and 
appeared to be in some pain. 
Collection of Samp l es 
Anima l pre pa r ation 
The animals of the control group were fasted overnight and three 
doses of "Goly te ly" 2 solu tion, 250 ml each were orally administered at 
12 hour intervals. 
Anesthesia was induced with sodium thiopental 20 mg/kg 
intravenously, and mr1intained by inhaL1rion with haloth<ine-oxygen. The 
large bowel was washed out by administration of 200 ml of the 
PEG/electrolyte solution into tlw colon v i a a rectal balloon catheter 
attached to a peristaltic infusion pump3 . This fluid was l eft inside for 
two minutes, and completely withdrawn by reversal of pump act ion. 
The same procedure was followed with the test animals except that 
they were not given Golytelv solution on t he day prior to lavage and 
2An isotonic solution containing polyethylene glycol (PEG) , sodium 
sulfate, sodium bicarbonate, sodium chloride and potassium chloride. 
3Ha r vard Apparatus , Millis, Mass. 02054 . 
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endoscopy. The only process of bowel cleansing used was the washing out 
immediately before infusion of the lavage solution. 
Collection of lavage samples and biopsy specimens 
To each animal in the control group, 300 ml of lavage solution was 
administered using the infusion pump and rectal balloon catheter. This 
fluid was left inside for 30 minutes before withdrawal. Immediately after 
withdrawal, lavage fluid was processed as described below. 
For the test animals, most of which were smaller in size, 250 ml 
was used instead of 300, and the time the fluid was left inside the colon 
ranged from 20 to 25 minutes, in order to minimize the time of 
anesthesia . 
After completion of colonoscopy, several biopsies from the colonic 
mucosa were taken from each subject . These included both normal looking 
and grossly abnormal areas in the case of test animals. A flexible 
fiberoptic endoscope 4 was used for colonoscopy. 
Biopsy specimens from each subject were fixed in formalin, embedded 
in paraffin, sectioned at 6 µm and stained with Hematoxylin and Eosin. 
Slides prepared from control and test animals were later examined 
"blindly" by one histopathologist. 
4Flexible Videoscope with o.o. of 9.2 mm 
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Processing of Samples 
Immediately after collection, the lavage samples were processed 
using the method described by Gaspari et al. (1988) with a few minor 
modifications. 
The samples (volumes approximately 150-200 ml) were placed in 50 ml 
polypropylene centrifuge tubes and centrifuged at 2000xg for 30 minutes 
in order to remove particulate matter. The supernatants were poured into 
clean tubes. In order to destroy any protease activity (which would 
interfere with IgG levels) in the samples, soybean trypsin inhibitor5 (1 
mg/ml) in phosphate bufferred saline (PBS) was added to each tube to a 
final concentration of 10% v/v. EDTA (1.0 M) in PBS was then added to a 
final concentration of 5% v/v. The tubes were centrifuged at 550xg for 10 
minutes, and the supernatant transferred to new tubes. 
Phenylmethylsulfonyl fluoride (PMSF), (100 mM) in 95% ethanol, was added 
to a final concentration of 1% v/v , and the tubes were centrifuged again 
at 2200xg for 30 minutes. The supernatants were removed into clean tubes, 
and PMSF was added again to a final concentration of 1% v/v. To these 
tubes, sodium azide (20 mg/ml) in PBS was added to a final concentration 
of 1% v/v. The tubes were left at room temperature for 15 minutes, and 
heat-inactivated calf serum was added to a final concentration of 4% v/v. 
From these tubes, 7 . 5 ml samples were taken for the myeloperoxidase assay 
(which was performed immediately after processing), and the rest were 
5Sigma Chemical Co., P.O. Box 14508, St. Louis, MO 63178 (Sigma). 
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divided into aliquots and stored at -70°c for future assays (nitrite, 
total protein and lgG). 
Assays 
Myeloperoxidase activity 
Myeloperoxidase activity on the processed samples was measured 
using the method described by Miller et al., 1991, which is a 
modification of the original method described by Bradley et al., 1982. 
To each 7.5 ml sample of lavage fluid, 0.25 ml of 15% 
hexadecyltrimethylammonium bromide in 50 mM potassium phosphate buffer6 
was added (a dilution of 30:1 v:v) in order to negate the 
pseudoperoxidase activity of hemoglobin. The tubes were sonicated for 15 
seconds to disrupt MPO containing cells for release of the enzyme. They 
were then centrifuged at 20,000xg for 15 minutes, and the supernatant 
taken for the spectrophotometric reaction . 
From this supernatant, a 100 µl aliquot was taken and mixed with 
2.9 ml of potassium phosphate buffer (50 mM, pH 6.0) containing 0.167 
mg/ml o-dianisidine dihydrochloride and 0.0006% hydrogen peroxide. The % 
transmittance at 460 nm was recorded spectrophotometrically7 at the end 
of each minute for 3 minutes . One unit of myeloperoxidase activity has 
6Mallinkrodt Chemical Works. 
7Beckman DB-GT Grating double beam spectrophotometer. 
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been defined as that required to degrade 1 µMol of hydrogen peroxide per 
minute at 25°C. 
Nitrite assay 
Since we suspected the levels of nitrite in these samples to be 
quite small, the samples were concentrated 2 to 12 fold by membrane 
centrifugation8 . Nitrite levels in the concentrated samples were 
measured using the method described by Roediger et al., 1986. 
One half ml of the sample was placed in a 3.5 ml cuvette and 2.0 ml 
of distilled water was added . To this, 0.5 ml of 1.6% sulfanilamide in 
3.6 N HCl was added. After mixing by inverting the cuvettes, the % 
transmittance at 540 nm was recorded spectrophotometrically, to determine 
blank values . Then, 125 µl of 0 . 1% N- (1-naphthyl) ethylenediamine was 
added, and the tube was left at room temperature for the color to 
develop. After 15 minutes the % transmittance at 540 run was recorded 
again . 
The corresponding optical density values were obtained from 
conversion tables and the difference in optical density between 0 and 15 
minutes was calculated. A standard curve was prepared using sodium 
nitrite solutions of 0 . 5, 1 . 0, 5.0 and 10.0 mMol/0.5ml, and the nitrite 
levels of the samples were calculated using this curve. 
Scentriperp 10 concentrators, Amicon Division, W.R. Grace Co., Beverley, 
MA 01915. 
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Total protein assay 
Total protein levels in lavage samples were measured with a 
Bicinchoninic Acid Protein Assay Kits 9 . The principle of this assay is 
the concentration dependent reduction of cu++ to cu+ by protein. 
Bicinchoninic acid reacts specifically with cu+, and forms a purple 
complex with an absorbance maximum at 562 nm . Protein standards were 
prepared with bovine serum albumin. 
Fifty ml of bicinchoninic acid solution was mixed with 1 ml of 
cupric sulfate pentahydrate (4%) solution, and 2 ml added to each sample 
or standard (0.1 ml). Samples were incubated at 37°C for 30 minutes, 
cooled to room temperature and the absorbance at 562 nm was measured 
spectrophotometrically . 
A standard curve was prepared by plotting the net absorbance at 
562 nm against the amount of protein in each standard tube in µg. The 
protein content in each lavage sample was calculated by comparison with 
this standard curve. 
Immunoglobulin G assay 
The assay was performed on lavage samples concentrated by membrane 
centrifugation as previously described . The method employed for the assay 
9sigma Chemical Co., P.O. Box 14508, St Louis, MO 63178 (Sigma). 
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was single radial immunodiffusion, using a commercial kit developed for 
Canine IgG10 . 
The kits consisted of plates of agarose gel into which antiserum 
specific for canine IgG had been incorporated, and four IgG standard 
solutions containing 225, 450, 900, and 1800 mg/100 ml respectively. 
Wells of 3 µl volume had been cut in the agar. From each standard IgG 
solution, 3 µl was placed in a well. In the remaining wells, 3 µl of the 
lavage samples to be tested were placed. The plates were left at room 
temperature for 18-24 hours, to allow the diffusion of the solutions in 
the wells into the surrounding agar. 
When the sample antigen reacted with the antibody in the agar, a 
ring of precipitation was formed around the well, whose diameter was 
proportionate to the concentration of antigen. The diameters of the rings 
were measured , a standard curve was prepared with the ring diameters of 
the IgG standard solutions, and the concentrations of IgG in the lavage 
samples were calculated by comparison with the standard curve. 
Analysis of Data 
The data (which included the levels of nitrite, total protein and 
IgG from each animal) were analyzed using ANOVA (Proc GLM). 
iocanine IgG SRID kits from Veterinary Medical Research and Development 
Inc. 
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RESULTS 
Histology 
Histopathological features of IBD were observed in the colonic 
biopsy specimens from all dogs in the test group (Figures 
3,4,5,6,7,8,9,10,11 and 12). These features included infiltration of 
lymphocytes and plasma cells in all cases and edema of the lamina 
propria, general or focal fibros i s and goblet cell hyperplasia in some 
cases . The degree of IBD varied from mild to severe . Two dogs (TS and T7) 
showed severe IBD and two dogs (T4 and T6) showed moderate IBD lesions, 
while all the rest were diagnosed as mild IBD. The biopsies from the 
control group showed normal histology (Figure 2) except for two cases (C4 
and C7) which showed mild IBD lesions . 
Recovery Rate 
The amount of fluid recovered varied with each animal, but was 
generally 60% or more of the infused volume . Lower recovery volumes in 
two control dogs (C4 and C6) , and two IBD cases (T2 and TlO) were due to 
leakage around the rectal ba lloon catheter . 
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Assays 
Myeloperoxidase: Myeloperoxidase activity was not detectable in 
colonic lavage samples from either control dogs or dogs with suspected 
IBO. 
Nitrite content: Nitrite levels in the lavage fluid of dogs with 
suspected IBO ranged from 0.02 to 3.75 mMol/ml with a mean of 1.83 
mMol/ml. These were significantly higher than those of the control group 
which ranged from 0 to 1.2 mMol/ml with a mean of 0.158 mMol/ml (Figure 
13, Tables 1 and 2). 
Total protein content: Total protein concentrations ranged from 228 
to 671 mg/dl (mean: 407) in the control dogs and ranged from 162 to 496 
mg/dl (mean: 392) in the dogs with suspected IBO. There was no 
significant difference between the total protein levels in the two groups 
(Figure 14, Tables 1 and 2). 
Immunoglobulin G content: The control group had no measurable IgG. 
In the test group, the IgG content ranged from 28 to 64 mg/dl, with a 
mean of 46 mg/dl. One sample in the test group, TS, had no detectable IgG 
(Figure 15, Tables 1 and 2) . 
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Table 1. Control group: Animal data and values. 
Animal Breed Sex Flui d in Fluid out Nitrite Total Protein IgG Histological 
ml ml mMol/ml mg/dl mg/dl diagnosis 
Cl Collie F 300 203 0.126 425 0 . 0 Normal 
C2 Gsa M 300 295 0.570 337 0 . 0 Normal 
C3 Chow F 300 210 0 . 170 384 0 . 0 Normal 
C4 Greyhound M 300 72 0 . 009 613 0 . 0 Mild IBO 
C5 Mix F 300 200 0 . 140 365 0 . 0 Normal 
cs Mix F 300 41 0.000 280 0 . 0 Normal 
C7 Pointer F 300 146 0 . 050 365 0 . 0 Normal 
ca Labrador M 250 121 1 .200 671 0 . 0 Normal 
C9 Spaniel M 250 170 0 . 036 228 0 . 0 Normal 
Mean 0 . 256 407 0 . 0 
SD 0 . 394 145 0 . 0 
a: German Shepard. 
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Table 2. Test Group: Animal data and values. 
Animal Bread Sex Fluid in Fluid out Nitrite Total Protein IgG Hiltoloaical 
ml ml ~l/ml mg/dl mg/dl diqnoail 
Tl Mix F 250 200 0 . 880 468 41. 07 Mild IBO 
T2 Terrier M 250 50 3 . 750 496 38.34 Mild IBO 
T3 Doberman F 250 170 0 . 021 162 0.0 Hild IBO 
T4 Mix F 250 113 0.305 453 58 . 52 Moderate IBO 
T5 Po in tar M 250 142 2 . 920 487 28.24 Severa IBO 
T6 Beagle F 250 220 1.190 332 22 . 53 Moderate IBO 
T7 Charpei M 240 196 1. 770 365 55 . 12 Severa IBO 
T8 Mix M 200 173 3 . 440 453 64 . 00 Mild IBD 
T9 csa F 250 240 3 . 330 382 61 . 00 Hild IBO 
TlO Mix M 250 96 0 . 730 425 52 . 30 Hild IBO 
Ma an 1.830 392 46 .00 
SD 1. 408 107 20.40 
a: Cocker Spaniel. 
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Figure 2. Colonic biopsy from a control animal. Hi stopathological 
diagnosis : Normal. (No significant lesions) 
Top: He matoxylin and Eosin. (x 160) 
Bo ttom: He matoxy lin and Eosin. (x 400) 
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Figure 3 : Co l on ic b i opsy from test animal # l . Histopathologica l 
diagnosis: Mild IBO, characlerized by infiltration of 
lymphocytes and plasma cells. 
Top: Hematoxylin and Eosi.n (x 160). 
Bottom: HemaLoxy lin dnd Eosin (x 400). 
6 2 
Figure 4: Co l on i c biopsy from test animal #2 . Histopathologi ca l 
d iagnosis : Mild IBD, characterized by infiltration of 
lymphocytes a nd p l asma cel l s . 
Top: Hematoxy l in and Eosin (x 160) . 
Bottom: Hematoxylin and Eosin (x 400) . 
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Figure 5. Colonic biopsy from test nnirnal #]. Hisropathological 
diagnosis: Mild IBD, characterized by mucosal edema and 
infiltration of lymphotytes and plasma cells. 
Top : Hernacoxy l in and l~osi11 (x 160). 
Bottom: Hematoxylin and Eosin (x 400). 
... ,. 
' 
? 
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Figure 6: Colonic biopsy from test animal #4. Histopathological 
diagnosis: Moderate IBO, character i zed by infiltration of 
lymphocytes and plnsma cells, glandular immaturity and mucosal 
edema. 
Top: 11Pmncoxy1in and Eosi11 (x 160). 
Bottom: Hemacoxyl in <Jncl F:osin (x £100). 
• 
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Figure 7: Colonic biopsy from test animal #5. Hi stopath ological 
diagnosis: Severe IBD, characterized by infil t ration of 
lymphocytes and plasma cel l s, dep l etion of goblet ce lls and 
fibrosis of lamina propria. 
Top: He matoxy lin nnd Eosin (x 160). 
BoLLom: Hematoxylin a11d r.osin (x 400) . 
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Figure 8: Colonic biopsy from test anima l #6 . Histopathological 
diagnosis: Moderate IBD, characterized by infiltration of 
lymphocytes and plasma cells. 
Top : Hematoxylin and Eosin (x 160). 
Bottom : Hematoxylin a nd Eosin (x 400). 
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Figure 9: Co l onic b iopsy from test animal ~7. Hi sLopathological 
diagnos i s: Severe IBO, characterized by severe deplet i on of 
goblet ce l ls and excessive infiltration of lymphocytes and 
plasma ce l ls. 
Top: Hematoxyl i n and Eosin (x 160). 
Bottom: Hematoxyl in Rnd Eosin (x 400). 
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Figure 10: Colonic biopsy from tesl m1im;il 1<'8. Histopathological 
diagnosis: Mild IBO, chnracceriz~d by infiltration of 
lymphocytes, plasma cells and eosinophils. 
Top: Hematoxylin and Eosin (x 160). 
Bottom: llematoxylin and Eosin (x 400). 
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Figure 11: Colonic biopsy from Lt·sL animal i+9. lli sLopathological 
diagnosis: Mile\ llm, c haracLerized by i11filtratio11 of 
lymphocytes and pln~ma cells, and goblet cell hyperplasia. 
Top: Hematoxylin and Eosin (x 160). 
Bottom: Hematoxyl in and Eosin (x 400). 
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Figure 12. Colonic biopsy (froz~n section) irom Lest animal ffl0 . 
Hi s lopalho1 og i cnl di ip.110~,is: Mild TBD, chnracterized by 
infiltration of l ymphocytl·s n11d plnsmn ce lls. 
Top: Hematoxylin nnd Eosin (xl60). 
Bottom: Hematoxylin and Eos in (x 400) . 
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Figure 15. Immunoglobulin G (IgG) concentrations in colonic lavage 
samples fr om nine control dogs (control group) and ten dogs 
diagnosed with IBD ( test group ). 
Values are mean± SD. * - p< 0.001. 
74 
DISCUSSION 
The purpose of the investigation was to determine whether 
inflammatory bowel disease is associated with elevated production of 
nitr i c oxid e and immunoglobulin G in the large intestine. The method of 
testing the hypothesis was LO measure Lhe levels of nitrite and IgG in 
colonic lavage fluid from healthy co11trol dogs and dogs with suspected 
IBD. Since nitric oxide is a highl y volaL ile compound, it's levels cannot 
be measured directly. Nitric oxide concentrations may be determined 
indirect l y by measuring the levels of its end product, nitrite i on . IgG, 
although suscept ibl e to proteolyLic enzy1nes, was preserved unti l assay by 
the use of protease inhibitors. llisLopaLhological examination of colonic 
biopsy spec imens for infla111mato1·y lt•s Lo11s, and measurement of the 
activity of myeloperoxidase (nn c·nzym£• conta ined in inflammatory cells ) 
in colonic lavage samples, were used Lo assess the degree of bowel 
inflammation in each animal. 
During colonoscopy, colonic biopsy spec imens were obta ined f rom 
each animal, from both inflamed and normal-appearing areas in the case of 
suspecLed lBD patients. Upon hisLological examinaLion of Lhese spec imens, 
1BD lesions of varying degree s wPn• 1·l'vvnled in all Lhe samples from the 
IBD group. According to the pathologist's diagnosis, of the ten dogs 
tested six dogs had mild IBO, two had moderate IBO and two s howed severe 
IBO. The predominant histopathological feature found in all cases was the 
infiltration of lymphocytes nncl plnsma ce lls. The degree of infi l trat ion 
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varied between cases. Eosinophilic infiltration was observed in one 
an imal (TS). One of the cases diagnosed wiLh severe IBD (TS) had 
extensive fibrosis of the lamina propria, indicating its chronic nature . 
Focal fibrosis of t h e lamina propria was observed in one of the cases 
with moderate IBD (T6). Other features like goblet cell hype rplasia, 
glandular immaturity and edema of the la1nina propria were observed 
occasionally. All the above findings confirm Lhe histopathologi cal 
picture of canine IBD as described i11 Lhe literature (Sherd ing and 
Burrows, 1992). In the control group, seve11 dogs showed normal histology 
wh i le two were diagnosed to have mild IBD. 
Myeloperoxidase (MPO ) activiLy i11 colonic lavage samples was not 
detectabJe in any of the samples Lc->sLecl, (despite immediate processing 
and analysis upon collection) eiLIH"r fro111 Lhe conLro l animals or from the 
animals with suspected IBD. This fi11di11g co11Lr<1sts with previous studie s 
where it was concluded that MPO activity is a reliable marke r for t he 
inflammatory cell content in a rabbit model of ileitis (Miller et al., 
1991), and in cutaneous inflammation in raLs (Bradley et al., 1982) . 
The principle source of MPO in an inflammatory lesion is the 
neutrophil (Bradley et al., 1982). llPnCl', tlw MPO activity may be 
considered a mflrker for neutrophd co11tC"11t 1·flt her tlrnn for the degree of 
inflammat ion . In human IBD, MPO ncLiviLy is a su i table indicator because 
the i nfla mmatory l es ions in ulceraLive colitis and Crohn ' s disease 
frequently contain e l evated numbers of neutrophils. In the cl inica l cases 
of the present study, the hiscopathological examination revealed chronic 
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i nflammatory lesions of varying degrees in all t h e a nimals suspected to 
have IBO. However, these l esions were c haracter i zed by p r edominant 
infil trat ion of lymphocytes a nd plasma ce l ls rath er than neutrophils. 
Eos inophi l ic infi l t ra tion was found occas i onally, but the numb e r of 
neutrophi l s in t h ese l esions was quite low. This may be t h e r eason for 
the undetectability of MPO in these samp l es. Furthermore , neutrophils are 
characteristic of acute rather t han chron i c infl ammation. Colonic biopsy 
specimens for this study were obta ined at one time only from each anima l , 
so t hat possible acute flare-ups of t he disease may have gone undetected. 
In t h e intest i ne, nitric oxide can be synth esized both by l uminal 
bacteria a nd by ni tric oxide synthase found in t h e intestinal e pithelial 
cel l s. A study with isolated rat intest ina l epith e lia l cel ls revea l e d the 
presence of both inducibl e and const i tutive forms of nitric oxide 
synth ase (NOS), determined by co nversion of 14 C arginine to citrulline . 
This conversion was inh i bi ted b y incubation with a NOS inhibitor, namely 
NG- monomethyl-L-arginine, an analogue of arginine (Tepperman et al., 
1993). Several studies in humans and ex per i me n ta l anima l s have r evealed 
elevated luminal nitrite levels associated with intestinal inflammation, 
suggestin g an elevated production of NO by intestinal epithel ial cells 
under an inflammatory st imulus . Upon analysis of rectal dia l ysates of 
h uman IBD patients, measurable l evels of nitrite were found i n a major ity 
of active IBO patients, while those with quiescent co l itis or the normal 
con tro l subj ects y i e lded no measurable nitr i te (Roediger et a l., 1 986 ). 
Elevated luminal ni t ri te levels were observed in a gu inea pig mode l of 
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chemically i nduced ileitis, and the chronic ileal infl amma tion was fo und 
to be ame l iora ted upon administrnrio11 of NOS inhibitors ( Mil l er et a l., 
1992) . In our investigation, colonic lavage nitrite l evels i n dogs wi t h 
I BO were si gni fica n tly higher thon t hose of normal dogs . The mean nitr i te 
leve l was over seven times h ighe r in the test group than in the contro l 
group. This finding suppor t s the conclusions of the above studies , 
suggest ing that canine IBO is also ossoc iated with elevated act i v i ty o f 
NOS in intestina l epithelial ce ll s. 111 our study , the IBO group ha d a 
higher standard deviaLion than Liiv Lest group, in both nitrite and IgG 
levels. This w<1s Lo be expected si11 c v i11 the patients we studied the 
disease had occurred naturally, so that the severity of disease varied 
among cases . 
I ntestinal lumen normally contains some prote ins, originat i ng f rom 
the diet, intest inal sec r etions, discnrded ep i thelial cel l s and lumi na l 
bacteria. The immunoglobulins found in the intestinal secretions are 
principa l ly IgA and some IgM , both of wh i ch are secreted from the mucos a l 
B l ymphocytes (Evans, 1984) . I gG is a type of immunoglobulin which i s not 
normally secreted from mucosal surfaces . IgG usua lly exerts its f unc t ion 
within the bloodstream, as do other plasma proteins like albumin. Such 
proteins do not normally enter the i11testinal lumen, since the epithelial 
liarr i c>r bc>twf'e 11 t lw bl0odsLrvn111 .111d i 111c•sti nal l umt>n i s impe r meable to 
these pro t eins . But, in intes tina 1 in Clamma tion, thi s mucosal ba r r i e r i s 
weakened, a l lowing t h e leakage of plasma proteins into the lume n . 
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Elevated levels of albumin and IgG have been found in the gut 
lavAge fluid from hum<rn IBO patiPnts (Chouclnri et al., 1993; O'Mahoney et 
al. , 1990). l n these stud i es, a specific i11crease of IgG levels in 
proportion to the disease activity has bee n observed, l eading to the 
conclusion that IgG may be a reliable marker for the degree of 
inflammation in IBD in humans. In our study, while t he r e was no 
significant difference between the total protein levels in co lonic lavage 
fluid from the two groups, the IgG l~vels in the diseased animals were 
found to be markedly elpvated 1-1lwn co111pnn·d to the control group which 
yielded no detectable IgG. This finding strongly supports the conclusions 
from t he previous stud i es, suggesLing that colonic lavage I gG is a 
r e liable indicator of canine inflammnLory bowel disease . 
lgG levels were undetectabl e i11 <ill the cinimals of the control 
group, including the two animals whicl1 showed histopathology indicative 
of mild IBD. One possible explanaLion is tlwL the histological lesions in 
these two anima ls might have been due to a bowel inflammation other t han 
IBD which is not no r mally characterized by elevated IgG. This theo r y is 
supported by the a b sence of clinical signs of IBO and the rema rkably low 
levels of colonic nitrite in these Lwo cnses. 
From the results of this invesli~ation ic can be conc luded t hat 
coloni c lavage nitr i te and IgG levels nre elevuLed in canine IBO. 
However, a correlation be tween thP clegree of disease and t he degree of 
increase of Lhese compounds cannot b" dc·tc-r111i11ed. \"1lile three cases o f 
mild IBO showed relatively high levels of nitrite and IgG, one case which 
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showed severe IBO had comparatively low levels of IgG and moderate l evels 
of nitrite. Si milarly, a correlation between the nitrite l evels and IgG 
levels was not obvious except in T3 where both were quite low. 
A possible reason fo r this lack of correlat ion in the nitrite 
levels with the disease activity might be the varying degree of NO 
p r oduct i on by coloni c bacteria, which was not accounted for i n t his 
study. There was no available method for making an allowance f or 
bacterial NO production , and we assumed it to be neglig ible since 
reasonably adequate bowel cleansing was done prior to obtain ing the 
lavage samples. However, since there is no known difference between t h e 
colonic bacte rial populat ions between nor1nal and IBO subjects, the 
difference in t he mean ni tr i te l evels between the two groups is 
sufficient to conclude that IBO has a marked influence on the i ntestina l 
epithelial NO synthesis. 
The role of NO in IBO is 11ot c l ear. Previous studies have suggested 
tha t NO may play a protective role in acute intest inal inflammation. The 
epithelial permeabi l ity in i solated feli ne small intestine, measur ed b y 
blood-to -lumen clearance of 51Cr-labeled EDTA, was markedly elevated upon 
inhibition of NOS, and was restored by administration of exogenous NO 
(Kubes, 1992). In a feline model of intestinal ischemia followed by 
reperfusion, thP intestinal mL1cosal bar r ie r disruption was reduced by 
exogenous NO (Payne and Kubes, 1993). In cont r ast, NO aggravates chron ic 
inflammation so that inhibition of NOS i s beneficial in such situat ions. 
In a guinea pig model of chemically induced chronic ileitis, oral 
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administration of a NOS i nhibitor ameliorated the intestinal damage, 
suggesting a harmful role for NO which is synth es ized in large amounts in 
this situation ( Miller e t al., 1992). To determine what role NO plays in 
canine IBO, further studies need to be conducted using NOS inhibitors. 
The conc lusion of the present investigation is that there is a 
significant increase in colonic lavage nitrite and IgG levels in canine 
IBD, and that these parameters may b e used as indicators of the presence 
of IBD. This may be a valuable diagnostic approach, s i nce colon ic lavage 
is an easy and non-invasive procedure and the measurement of nitrite and 
IgG is rap id and convenienL . The qun nt· i fi.cation of lgG by radial 
immunoassay is a parti c ul a rly easy and accura te method, a nd may be used 
as a quick diagnostic ma rker for canin e IBD. The elevat ion of nitrite 
levels indicate increased activity of intestinal epithelial NOS in canine 
IBD. Fol lowing furthe r studies to determine what role NO plays in the 
inflammato ry process, pharmacologi c modification of intestinal NOS 
activity may serve as a valuab l e therape ut i c app roac h to canine IBD. 
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